Wuhan Kemeide Biomedical

Wuhan Kemeide Biomedical is a biotechnology company headquartered in Wuhan, China, that specializes in the development and manufacture of high-quality recombinant proteins and antibodies. Founded in 2014, the company provides essential raw materials and technical services to the in vitro diagnostics (IVD) and biopharmaceutical industries. Their core expertise lies in protein expression and purification across various systems, including E. coli, yeast, and mammalian cells. Kemeide's product portfolio includes diagnostic enzymes, cytokines, and customized antibody services designed to support clinical research and diagnostic kit production. The company operates out of the Wuhan Biolake national bio-industry base, leveraging advanced R&D facilities to serve a global client base.